<DOC>
	<DOC>NCT01318772</DOC>
	<brief_summary>The purpose of this study is to acquire the clinical data required by the United States Food and Drug Administration (USFDA) for 510(k) submission, for approval of a new high resolution imaging system for fluoroscopy/radiography. It is expected that the new KALARE (DREX-KL80)high resolution imaging system will meet the design specifications. A minimum of 30 cases will be submitted for evaluation of claims for intended clinical applications.</brief_summary>
	<brief_title>Clinical Image Evaluation for the DREX-KL80 Imaging System</brief_title>
	<detailed_description />
	<criteria>Male and female patient 18 years and older Not pregnant Not a safety risk patient Male and female patient under 18 years old Pregnant subjects High safety risk subjects Subjects and/or Legal Guardian Unable to provide informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>